Company Filing History:
Years Active: 2015
Title: The Innovations of Englbert Bäuml
Introduction
Englbert Bäuml is a notable inventor based in Gross Grönau, Germany. He has made significant contributions to the field of macromolecular nucleotide compounds. His work focuses on the development of innovative structures that enhance the synthesis of nucleic acids.
Latest Patents
Englbert Bäuml holds a patent for "Macromolecular nucleotide compounds and methods for using the same." This invention describes new structures of nucleotide conjugates, which comprise at least one nucleotide moiety coupled to a macromolecular compound via a short linker. These conjugates can serve as substrates for various polymerizing enzymes in the enzymatic synthesis of nucleic acids. In particular, these compounds can be utilized for labeling nucleic acids.
Career Highlights
Englbert Bäuml is associated with Genovoxx GmbH, where he continues to innovate in the field of biotechnology. His work has the potential to impact various applications in genetic research and molecular biology.
Collaborations
Englbert collaborates with Dmitry Cherkasov, contributing to advancements in their shared field of expertise.
Conclusion
Englbert Bäuml's innovative work in macromolecular nucleotide compounds showcases his dedication to advancing biotechnology. His contributions are paving the way for new methodologies in nucleic acid synthesis and labeling.